Clinical Trials for Mesothelioma Patients: Pazopanib Inclusion Criteria
Read the inclusion criteria about a current clinical trial being conducted to study the effects of Pazopanib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Inclusion Criteria:
Histologically or cytologically confirmed malignant pleural mesothelioma o Measurable disease o No progressive disease inside or outside of any prior radiation field
No symptomatic, untreated, or uncontrolled CNS metastases o Patients with CNS metastases treated with whole brain radiation (WBRT) may be enrolled after completion of WBRT
Patients may begin study therapy as early as the next day after completion of WBRT
Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)
“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”
-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg
Study description of Cisplatin and Pemetrexed on mesothelioma cancer